Dr Berger founded Health Intelligence Partners 6 years ago as a healthcare consultancy that blends more than 25 years of both business and clinical experience. Prior to founding Health Intelligence Partners, Dr Berger served as senior vice president and chief clinical officer for CVS Caremark. She presently sits on the boards of Care Core National (committees: finance, compensation, search, mergers & acquisitions, and strategic directions), Meals to Heal, The University of Arizona School of Pharmacy, RxAnte, and Midwest Business Group on Health. Dr Berger is the editor-in-chief of The American Journal of Pharmacy Benefits.
Amy Berman, BS, RN
Senior Program Officer
The John A. Hartford Foundation
Berman is a senior program officer with the John A. Hartford Foundation. She heads the Foundation’s development and dissemination of innovative, costeffective models of care that improve health outcomes for older adults. She works to advance palliative care and to reduce avoidable readmissions. Berman also works on collaborations with federal partners, including the Centers for Medicare & Medicaid Innovation, the Office of the National Coordinator for Health Information Technology, and the Administration for Community Living. She has openly shared her experiences living with stage IV breast cancer, presenting to the Institute on Medicine.
See pages SP69, SP70, SP71, SP75, SP85, SP88
Michael E. Chernew, PhD
The American Journal of Managed Care
Dr Chernew is the Leonard D. Schaeffer Professor of Health Care Policy at Harvard Medical School. His research activities focus on several areas, most notably the causes and consequences of growth in healthcare expenditures, geographic variation in medical spending, and use of Value-Based Insurance Design. Dr Chernew is vice chair of the Medicare Payment Advisory Commission, an independent agency established to advise the US Congress on issues affecting the Medicare program. He is also a member of the Congressional Budget Office’s Panel of Health Advisors. In 2010, Dr Chernew was elected to the Institute of Medicine of the National Academy of Sciences; he served on the Committee on the Determination of Essential Health Benefits.
See pages SP91, SP92
VP of Reimbursement & Payer Strategy
Foundation Medicine, Inc
Conway joined Foundation Medicine Inc in May 2012 with over 22 years of sales and executive management experience in the routine clinical and esoteric laboratory marketplaces. His experience includes payer contracting and reimbursement in a wide range of business environments, including Fortune 500 and start-up companies. He has previously worked for Metamark Genetics Inc, a national provider of cancer prognostic tests and services, as vice president of reimbursement and payer contracting.
See pages SP88, SP90
Jeffrey D. Dunn, PharmD, MBA
PDF is available on the last page.